Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P030031/S144

THERMOCOOL SMARTTOUCH SF (Uni-Directional and Bi-Directional)/DUAL ENERGYTHERMOCOOL SMARTTOUCH SF CATHETERS

Biosense Webster, Inc. · Decision date Jun 10, 2026

FDA DECISIONP030031/S144

What did the FDA decide?

FDA records P030031/S144 as a supplement to PMA P030031, with the supplement type “30-Day Notice”. The recorded decision is OK30 (30-day notice), dated Jun 10, 2026.

FDA approval order statement

an additional supplier for critical components
Regulatory pathway
PMA supplement
Supplement type
30-Day Notice
Clinical specialty
Cardiovascular
Decision date
Jun 10, 2026
FDA change category
Process Change - Manufacturer/Sterilizer/Packager/Supplier

FDA source record

Regulatory record facts

Identifier
P030031/S144
Regulatory pathway
PMA supplement
Product code
OAD
Decision code
OK30
Decision date
Jun 10, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: catheter, percutaneous, cardiac ablation, for treatment of atrial flutter.

Product code
OAD
FDA device class
3

For the original device and its historical approval scope, see PMA P030031. Subsequent supplements may change the device or its indications.

FDA decision timeline

  1. P030031 · Original PMA

    BIOSENSE WEBSTER NAVISTAR/CELSIUS THERMO COOL DIAGNOSTIC/ABLATION DEFLECTABLE TIP CATHETERS

  2. P030031/S144 received

    Application receipt date recorded by FDA.

  3. P030031/S144 · FDA decision

    30-Day Notice

  4. P030031/S143 · Related supplement

    VISITAG SURPOINT External Processing Unit (EPU); CARTO 3 System

  5. P030031/S141 · Related supplement

    Dual Energy THERMOCOOL SMARTTOUCH SF System

  6. P030031/S142 · Related supplement

    THERMOCOOL SMARTTOUCH SF Catheter

  7. P030031/S146 · Related supplement

    EZ STEER THERMOCOOL NAV BI-DIRECTIONAL ELECTROPHYSIOLOGY CATHETER; THERMOCOOL SMARTTOUCH BI-DIRECTIONAL NAVIGATION CATHE

Timeline entries are records held by MedtechLedger for P030031. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P030031

Explore the linked device profile

Other records with product code OAD

Product / regulatory recordCompanyPathwayDecision dateSource
Irvine Biomedical,Inc.(Ibi)PMA supplementSep 3, 2026FDA
Ampere GeneratorP040042/S059
Irvine Biomedical,Inc.(Ibi)PMA supplementAug 7, 2026FDA
Ampere GeneratorP060019/S059
Irvine Biomedical, Inc.PMA supplementAug 7, 2026FDA
Ampere GeneratorP110016/S095
ABBOTT MEDICALPMA supplementAug 7, 2026FDA
ABBOTT MEDICALPMA supplementJun 5, 2026FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Biosense Webster, Inc.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
31 Technology Dr., Suite 200, Irvine, CA, 92618

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records